The Global Thyroid Ablation Devices Market size is expected to reach $289.9 Million by 2028, rising at a market growth of 13.0% CAGR during the forecast period.
Thyroid ablation devices are used inthe treatment of thyroid nodules and thyroid cancer. The thyroid glandis situated at the front of the throat, where thyroid cancer typically manifests as a nodule or lump. Thyroid cancer occurswhen rogue cells proliferate too quickly for the immune system to handle.
At the bottom of the throat, close to the trachea, the thyroid gland is present. It has two lobes on each side, left and right, so that it takes the shape similar to a butterfly. The isthmus, a slender section of tissue, joins the two lobes. The size of a healthy thyroid is comparable to a walnut. Normally, it is impossible to feel the thyroid through the skin. Iodine, a mineral present in various foods and iodized salt, is used by the thyroid to aid in the production of numerous hormones.
Thyroid manages the body temperature, heart rate, and the speed at which food turns into energy (metabolism). It also controlsthe blood's calcium levels. Men and women between the ages of 45 and 64 are most frequently diagnosed with thyroid cancer. However, women between the ages of 20 and 34 aremost frequently diagnosed with thyroid cancer. Additionally,thyroid cancer is nearly three times more common in women than in men.
There has been an increase in thyroid cancer diagnoses in the world, although there has been no change in the number of fatalities from the disease. The rate of thyroid tumors less than 1 centimeter in size is declining, and the growth in thyroid cancer rates seems to be leveling off in recent years. The majority of thyroid cancer cases respond to therapy and are typically cured.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Theraclion SA, Olympus Corporation, Terumo Corporation, BVM Medical Limited, MedWaves, Inc., and STARmed Co. Ltd.
Thyroid ablation devices are used inthe treatment of thyroid nodules and thyroid cancer. The thyroid glandis situated at the front of the throat, where thyroid cancer typically manifests as a nodule or lump. Thyroid cancer occurswhen rogue cells proliferate too quickly for the immune system to handle.
At the bottom of the throat, close to the trachea, the thyroid gland is present. It has two lobes on each side, left and right, so that it takes the shape similar to a butterfly. The isthmus, a slender section of tissue, joins the two lobes. The size of a healthy thyroid is comparable to a walnut. Normally, it is impossible to feel the thyroid through the skin. Iodine, a mineral present in various foods and iodized salt, is used by the thyroid to aid in the production of numerous hormones.
Thyroid manages the body temperature, heart rate, and the speed at which food turns into energy (metabolism). It also controlsthe blood's calcium levels. Men and women between the ages of 45 and 64 are most frequently diagnosed with thyroid cancer. However, women between the ages of 20 and 34 aremost frequently diagnosed with thyroid cancer. Additionally,thyroid cancer is nearly three times more common in women than in men.
There has been an increase in thyroid cancer diagnoses in the world, although there has been no change in the number of fatalities from the disease. The rate of thyroid tumors less than 1 centimeter in size is declining, and the growth in thyroid cancer rates seems to be leveling off in recent years. The majority of thyroid cancer cases respond to therapy and are typically cured.
COVID-19 Impact Analysis
Market participants in theablation devicessaw a decline in sales during the first few months of the pandemic. Revenuedecreased as a result of unfavorable adjustments to rules and regulations made by concerned authorities. When compared to healthy people, individuals with cancer and other disorders hada higher chance of contracting COVID-19 infection, according to the majority of regulatory organizations around the world. In order to protect patients from COVID-19, the diagnosis, surgeries, and examinations were constrained or delayed. The market growth thus slowed down for the first few months but is anticipated to pick up speed steadily in the following years.Market Growth Factors
Increasing need for thyroid ablation devices owing to the rise in thyroid nodules and cancers
Themarket for thyroid ablation devices is being driven by the increase in thyroid cancer & thyroid nodules, the demand for minimally invasive procedures, and the introduction of more advanced technological thyroid ablation devices. The demand for thyroid ablation is growing as a result of the factors described above, which is driving the market for thyroid ablation devices ahead. According to the American Cancer Society (ACS), by 2023, 43,720 people (31,180 women and 12,540 men) in the USmay have thyroid cancer at the time of their diagnosis.Rise in the number of researches in the world
The majority of thyroid malignancies are detected early and are curable. However, scientists are investigating which thyroid cancer patients can safely choose less treatment for their illness, reducing adverse effects. In addition, new treatments for thyroid cancers that are more uncommon and aggressive also require research. However, in recent years, NCI-funded researchers have created genomic assays to determine if such ambiguous nodules require surgery and are malignant. These exams could potentially save a lot of people from needless surgery. This would allow more people to opt for ablation surgeries and propel the market's growth.
Market Restraining Factors
Potential side effects of thyroid RFA ablation
Hypothyroidism develops when the thyroid cannot produce the appropriate level of thyroid hormones. In addition to weight gain and reduced sperm counts in men, women may experience irregular menstrual cycles. In addition, thyroid surgery could harm thyroid function, lowering the TSH levels and necessitating thyroid medication. RFA mayresultin permanent hypothyroidism, though rarely. These side effects may discourage patients from opting and undergoing ablation therapies and thus may hamper the growth of the market.Type Outlook
Based on type, the thyroid ablation devices market is categorized into radiofrequency ablation, microwave ablation, and others. The microwave ablation segment procured a considerable growth rate in the thyroid ablation devices market in 2021. Benefits like a faster treatment time, a broader ablation zone, as well as less heat sink impact, can be credited for the expansion of this segment. An MWA system usually consists of a flexible cable along with an antenna anda generator. High-frequency electromagnetic waves that havefrequencies ranging from 915 MHz to 2450 GHz are used in this method.Product Outlook
On the basis of product, the thyroid ablation devices market is divided into thermal-based devices and non-thermal-based devices. The non-thermal-based devices segment recorded a significant revenue share in the thyroid ablation devices market in 2021. Devices that do not use heat can only damage cells, preserving the functional properties of extracellular structures. Thus, utilizing non-thermal-based technologies, it is feasible to safely andeffectively ablate tissues near large blood vessels, the esophagus, or nerves. This demonstrates the efficacy of thyroid ablation close to the esophagus.Application Outlook
Based on application, the thyroid ablation devices market is segmented into thyroid cancer and thyroid nodules. The high growth can be ascribed to the rising incidence of thyroid cancer worldwide. For instance, the International Agency for Research on Cancer projects that in 2025, there will be 1,984,927 instances of thyroid cancer. The expected number of thyroid cancer fatalities worldwide in 2020 was 43,646. During the projection period, it is anticipated that the aforementioned reasons will support segment expansion.End - Use Outlook
On the basis of end-use, the thyroid ablation devices market is fragmented into hospitals, ambulatory surgical centers (ASCs), cancer specialty centers, and others. The hospitals segment procured the highest revenue share in the thyroid ablation devices market in 2021. Due to the ease of managing any problems that may occur following surgical procedures and the availability of a broad range of treatment options hospitals are preferred by most people. This is the main factor propelling the growth of the segment. Hospitals are furnished with technologically sophisticated medical devices and treat a substantially higher number of patients than other healthcare settings.Regional Outlook
Based on region, the thyroid ablation devices market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the largest revenue share in the thyroid ablation devices market in 2021. The occurrence of thyroid cancer is rising, there are important participants in the market, and consumers have high purchasing power, all of which are significant drivers in the development of the regional market. For instance, the Centers for Disease Control and Prevention (CDC) estimated that there were 45311 thyroid cancer cases recorded in the United States in 2019.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Theraclion SA, Olympus Corporation, Terumo Corporation, BVM Medical Limited, MedWaves, Inc., and STARmed Co. Ltd.
Scope of the Study
By End-use
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Cancer Specialty Centers
- Others
By Type
- Radiofrequency Ablation
- Microwave Ablation
- Others
By Application
- Thyroid Cancer
- Thyroid Nodules
By Product
- Thermal-based Devices
- Non-thermal-based Devices
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Boston Scientific Corporation
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson
- Theraclion SA
- Olympus Corporation
- Terumo Corporation
- BVM Medical Limited
- MedWaves, Inc.
- STARmed Co. Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Thyroid Ablation Devices Market, by End-use
1.4.2 Global Thyroid Ablation Devices Market, by Type
1.4.3 Global Thyroid Ablation Devices Market, by Application
1.4.4 Global Thyroid Ablation Devices Market, by Product
1.4.5 Global Thyroid Ablation Devices Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Thyroid Ablation Devices Market by End-use
3.1 Global Hospitals Market by Region
3.2 Global Ambulatory Surgical Centers (ASCs) Market by Region
3.3 Global Cancer Specialty Centers Market by Region
3.4 Global Others Market by Region
Chapter 4. Global Thyroid Ablation Devices Market by Type
4.1 Global Radiofrequency Ablation Market by Region
4.2 Global Microwave Ablation Market by Region
4.3 Global Others Market by Region
Chapter 5. Global Thyroid Ablation Devices Market by Application
5.1 Global Thyroid Cancer Market by Region
5.2 Global Thyroid Nodules Market by Region
Chapter 6. Global Thyroid Ablation Devices Market by Product
6.1 Global Thermal-based Devices Market by Region
6.2 Global Non-thermal-based Devices Market by Region
Chapter 7. Global Thyroid Ablation Devices Market by Region
7.1 North America Thyroid Ablation Devices Market
7.1.1 North America Thyroid Ablation Devices Market by End-use
7.1.1.1 North America Hospitals Market by Country
7.1.1.2 North America Ambulatory Surgical Centers (ASCs) Market by Country
7.1.1.3 North America Cancer Specialty Centers Market by Country
7.1.1.4 North America Others Market by Country
7.1.2 North America Thyroid Ablation Devices Market by Type
7.1.2.1 North America Radiofrequency Ablation Market by Country
7.1.2.2 North America Microwave Ablation Market by Country
7.1.2.3 North America Others Market by Country
7.1.3 North America Thyroid Ablation Devices Market by Application
7.1.3.1 North America Thyroid Cancer Market by Country
7.1.3.2 North America Thyroid Nodules Market by Country
7.1.4 North America Thyroid Ablation Devices Market by Product
7.1.4.1 North America Thermal-based Devices Market by Country
7.1.4.2 North America Non-thermal-based Devices Market by Country
7.1.5 North America Thyroid Ablation Devices Market by Country
7.1.5.1 US Thyroid Ablation Devices Market
7.1.5.1.1 US Thyroid Ablation Devices Market by End-use
7.1.5.1.2 US Thyroid Ablation Devices Market by Type
7.1.5.1.3 US Thyroid Ablation Devices Market by Application
7.1.5.1.4 US Thyroid Ablation Devices Market by Product
7.1.5.2 Canada Thyroid Ablation Devices Market
7.1.5.2.1 Canada Thyroid Ablation Devices Market by End-use
7.1.5.2.2 Canada Thyroid Ablation Devices Market by Type
7.1.5.2.3 Canada Thyroid Ablation Devices Market by Application
7.1.5.2.4 Canada Thyroid Ablation Devices Market by Product
7.1.5.3 Mexico Thyroid Ablation Devices Market
7.1.5.3.1 Mexico Thyroid Ablation Devices Market by End-use
7.1.5.3.2 Mexico Thyroid Ablation Devices Market by Type
7.1.5.3.3 Mexico Thyroid Ablation Devices Market by Application
7.1.5.3.4 Mexico Thyroid Ablation Devices Market by Product
7.1.5.4 Rest of North America Thyroid Ablation Devices Market
7.1.5.4.1 Rest of North America Thyroid Ablation Devices Market by End-use
7.1.5.4.2 Rest of North America Thyroid Ablation Devices Market by Type
7.1.5.4.3 Rest of North America Thyroid Ablation Devices Market by Application
7.1.5.4.4 Rest of North America Thyroid Ablation Devices Market by Product
7.2 Europe Thyroid Ablation Devices Market
7.2.1 Europe Thyroid Ablation Devices Market by End-use
7.2.1.1 Europe Hospitals Market by Country
7.2.1.2 Europe Ambulatory Surgical Centers (ASCs) Market by Country
7.2.1.3 Europe Cancer Specialty Centers Market by Country
7.2.1.4 Europe Others Market by Country
7.2.2 Europe Thyroid Ablation Devices Market by Type
7.2.2.1 Europe Radiofrequency Ablation Market by Country
7.2.2.2 Europe Microwave Ablation Market by Country
7.2.2.3 Europe Others Market by Country
7.2.3 Europe Thyroid Ablation Devices Market by Application
7.2.3.1 Europe Thyroid Cancer Market by Country
7.2.3.2 Europe Thyroid Nodules Market by Country
7.2.4 Europe Thyroid Ablation Devices Market by Product
7.2.4.1 Europe Thermal-based Devices Market by Country
7.2.4.2 Europe Non-thermal-based Devices Market by Country
7.2.5 Europe Thyroid Ablation Devices Market by Country
7.2.5.1 Germany Thyroid Ablation Devices Market
7.2.5.1.1 Germany Thyroid Ablation Devices Market by End-use
7.2.5.1.2 Germany Thyroid Ablation Devices Market by Type
7.2.5.1.3 Germany Thyroid Ablation Devices Market by Application
7.2.5.1.4 Germany Thyroid Ablation Devices Market by Product
7.2.5.2 UK Thyroid Ablation Devices Market
7.2.5.2.1 UK Thyroid Ablation Devices Market by End-use
7.2.5.2.2 UK Thyroid Ablation Devices Market by Type
7.2.5.2.3 UK Thyroid Ablation Devices Market by Application
7.2.5.2.4 UK Thyroid Ablation Devices Market by Product
7.2.5.3 France Thyroid Ablation Devices Market
7.2.5.3.1 France Thyroid Ablation Devices Market by End-use
7.2.5.3.2 France Thyroid Ablation Devices Market by Type
7.2.5.3.3 France Thyroid Ablation Devices Market by Application
7.2.5.3.4 France Thyroid Ablation Devices Market by Product
7.2.5.4 Russia Thyroid Ablation Devices Market
7.2.5.4.1 Russia Thyroid Ablation Devices Market by End-use
7.2.5.4.2 Russia Thyroid Ablation Devices Market by Type
7.2.5.4.3 Russia Thyroid Ablation Devices Market by Application
7.2.5.4.4 Russia Thyroid Ablation Devices Market by Product
7.2.5.5 Spain Thyroid Ablation Devices Market
7.2.5.5.1 Spain Thyroid Ablation Devices Market by End-use
7.2.5.5.2 Spain Thyroid Ablation Devices Market by Type
7.2.5.5.3 Spain Thyroid Ablation Devices Market by Application
7.2.5.5.4 Spain Thyroid Ablation Devices Market by Product
7.2.5.6 Italy Thyroid Ablation Devices Market
7.2.5.6.1 Italy Thyroid Ablation Devices Market by End-use
7.2.5.6.2 Italy Thyroid Ablation Devices Market by Type
7.2.5.6.3 Italy Thyroid Ablation Devices Market by Application
7.2.5.6.4 Italy Thyroid Ablation Devices Market by Product
7.2.5.7 Rest of Europe Thyroid Ablation Devices Market
7.2.5.7.1 Rest of Europe Thyroid Ablation Devices Market by End-use
7.2.5.7.2 Rest of Europe Thyroid Ablation Devices Market by Type
7.2.5.7.3 Rest of Europe Thyroid Ablation Devices Market by Application
7.2.5.7.4 Rest of Europe Thyroid Ablation Devices Market by Product
7.3 Asia Pacific Thyroid Ablation Devices Market
7.3.1 Asia Pacific Thyroid Ablation Devices Market by End-use
7.3.1.1 Asia Pacific Hospitals Market by Country
7.3.1.2 Asia Pacific Ambulatory Surgical Centers (ASCs) Market by Country
7.3.1.3 Asia Pacific Cancer Specialty Centers Market by Country
7.3.1.4 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Thyroid Ablation Devices Market by Type
7.3.2.1 Asia Pacific Radiofrequency Ablation Market by Country
7.3.2.2 Asia Pacific Microwave Ablation Market by Country
7.3.2.3 Asia Pacific Others Market by Country
7.3.3 Asia Pacific Thyroid Ablation Devices Market by Application
7.3.3.1 Asia Pacific Thyroid Cancer Market by Country
7.3.3.2 Asia Pacific Thyroid Nodules Market by Country
7.3.4 Asia Pacific Thyroid Ablation Devices Market by Product
7.3.4.1 Asia Pacific Thermal-based Devices Market by Country
7.3.4.2 Asia Pacific Non-thermal-based Devices Market by Country
7.3.5 Asia Pacific Thyroid Ablation Devices Market by Country
7.3.5.1 China Thyroid Ablation Devices Market
7.3.5.1.1 China Thyroid Ablation Devices Market by End-use
7.3.5.1.2 China Thyroid Ablation Devices Market by Type
7.3.5.1.3 China Thyroid Ablation Devices Market by Application
7.3.5.1.4 China Thyroid Ablation Devices Market by Product
7.3.5.2 Japan Thyroid Ablation Devices Market
7.3.5.2.1 Japan Thyroid Ablation Devices Market by End-use
7.3.5.2.2 Japan Thyroid Ablation Devices Market by Type
7.3.5.2.3 Japan Thyroid Ablation Devices Market by Application
7.3.5.2.4 Japan Thyroid Ablation Devices Market by Product
7.3.5.3 India Thyroid Ablation Devices Market
7.3.5.3.1 India Thyroid Ablation Devices Market by End-use
7.3.5.3.2 India Thyroid Ablation Devices Market by Type
7.3.5.3.3 India Thyroid Ablation Devices Market by Application
7.3.5.3.4 India Thyroid Ablation Devices Market by Product
7.3.5.4 South Korea Thyroid Ablation Devices Market
7.3.5.4.1 South Korea Thyroid Ablation Devices Market by End-use
7.3.5.4.2 South Korea Thyroid Ablation Devices Market by Type
7.3.5.4.3 South Korea Thyroid Ablation Devices Market by Application
7.3.5.4.4 South Korea Thyroid Ablation Devices Market by Product
7.3.5.5 Singapore Thyroid Ablation Devices Market
7.3.5.5.1 Singapore Thyroid Ablation Devices Market by End-use
7.3.5.5.2 Singapore Thyroid Ablation Devices Market by Type
7.3.5.5.3 Singapore Thyroid Ablation Devices Market by Application
7.3.5.5.4 Singapore Thyroid Ablation Devices Market by Product
7.3.5.6 Malaysia Thyroid Ablation Devices Market
7.3.5.6.1 Malaysia Thyroid Ablation Devices Market by End-use
7.3.5.6.2 Malaysia Thyroid Ablation Devices Market by Type
7.3.5.6.3 Malaysia Thyroid Ablation Devices Market by Application
7.3.5.6.4 Malaysia Thyroid Ablation Devices Market by Product
7.3.5.7 Rest of Asia Pacific Thyroid Ablation Devices Market
7.3.5.7.1 Rest of Asia Pacific Thyroid Ablation Devices Market by End-use
7.3.5.7.2 Rest of Asia Pacific Thyroid Ablation Devices Market by Type
7.3.5.7.3 Rest of Asia Pacific Thyroid Ablation Devices Market by Application
7.3.5.7.4 Rest of Asia Pacific Thyroid Ablation Devices Market by Product
7.4 LAMEA Thyroid Ablation Devices Market
7.4.1 LAMEA Thyroid Ablation Devices Market by End-use
7.4.1.1 LAMEA Hospitals Market by Country
7.4.1.2 LAMEA Ambulatory Surgical Centers (ASCs) Market by Country
7.4.1.3 LAMEA Cancer Specialty Centers Market by Country
7.4.1.4 LAMEA Others Market by Country
7.4.2 LAMEA Thyroid Ablation Devices Market by Type
7.4.2.1 LAMEA Radiofrequency Ablation Market by Country
7.4.2.2 LAMEA Microwave Ablation Market by Country
7.4.2.3 LAMEA Others Market by Country
7.4.3 LAMEA Thyroid Ablation Devices Market by Application
7.4.3.1 LAMEA Thyroid Cancer Market by Country
7.4.3.2 LAMEA Thyroid Nodules Market by Country
7.4.4 LAMEA Thyroid Ablation Devices Market by Product
7.4.4.1 LAMEA Thermal-based Devices Market by Country
7.4.4.2 LAMEA Non-thermal-based Devices Market by Country
7.4.5 LAMEA Thyroid Ablation Devices Market by Country
7.4.5.1 Brazil Thyroid Ablation Devices Market
7.4.5.1.1 Brazil Thyroid Ablation Devices Market by End-use
7.4.5.1.2 Brazil Thyroid Ablation Devices Market by Type
7.4.5.1.3 Brazil Thyroid Ablation Devices Market by Application
7.4.5.1.4 Brazil Thyroid Ablation Devices Market by Product
7.4.5.2 Argentina Thyroid Ablation Devices Market
7.4.5.2.1 Argentina Thyroid Ablation Devices Market by End-use
7.4.5.2.2 Argentina Thyroid Ablation Devices Market by Type
7.4.5.2.3 Argentina Thyroid Ablation Devices Market by Application
7.4.5.2.4 Argentina Thyroid Ablation Devices Market by Product
7.4.5.3 UAE Thyroid Ablation Devices Market
7.4.5.3.1 UAE Thyroid Ablation Devices Market by End-use
7.4.5.3.2 UAE Thyroid Ablation Devices Market by Type
7.4.5.3.3 UAE Thyroid Ablation Devices Market by Application
7.4.5.3.4 UAE Thyroid Ablation Devices Market by Product
7.4.5.4 Saudi Arabia Thyroid Ablation Devices Market
7.4.5.4.1 Saudi Arabia Thyroid Ablation Devices Market by End-use
7.4.5.4.2 Saudi Arabia Thyroid Ablation Devices Market by Type
7.4.5.4.3 Saudi Arabia Thyroid Ablation Devices Market by Application
7.4.5.4.4 Saudi Arabia Thyroid Ablation Devices Market by Product
7.4.5.5 South Africa Thyroid Ablation Devices Market
7.4.5.5.1 South Africa Thyroid Ablation Devices Market by End-use
7.4.5.5.2 South Africa Thyroid Ablation Devices Market by Type
7.4.5.5.3 South Africa Thyroid Ablation Devices Market by Application
7.4.5.5.4 South Africa Thyroid Ablation Devices Market by Product
7.4.5.6 Nigeria Thyroid Ablation Devices Market
7.4.5.6.1 Nigeria Thyroid Ablation Devices Market by End-use
7.4.5.6.2 Nigeria Thyroid Ablation Devices Market by Type
7.4.5.6.3 Nigeria Thyroid Ablation Devices Market by Application
7.4.5.6.4 Nigeria Thyroid Ablation Devices Market by Product
7.4.5.7 Rest of LAMEA Thyroid Ablation Devices Market
7.4.5.7.1 Rest of LAMEA Thyroid Ablation Devices Market by End-use
7.4.5.7.2 Rest of LAMEA Thyroid Ablation Devices Market by Type
7.4.5.7.3 Rest of LAMEA Thyroid Ablation Devices Market by Application
7.4.5.7.4 Rest of LAMEA Thyroid Ablation Devices Market by Product
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Boston Scientific Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Integra LifeSciences Holdings Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Johnson & Johnson
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental &Regional Analysis
8.4.4 Research & Development Expenses
8.5 Theraclion SA
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.6 Olympus Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.7 Terumo Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Regional Analysis
8.8 BVM Medical Limited
8.8.1 Company Overview
8.9 MedWaves, Inc.
8.9.1 Company Overview
8.10. STARmed Co. Ltd.
8.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Boston Scientific Corporation
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson
- Theraclion SA
- Olympus Corporation
- Terumo Corporation
- BVM Medical Limited
- MedWaves, Inc.
- STARmed Co. Ltd.
Methodology
LOADING...
